Skip to main content
. Author manuscript; available in PMC: 2023 May 2.
Published in final edited form as: Sci Immunol. 2016 Jun 23;1(1):aaf6925. doi: 10.1126/sciimmunol.aaf6925

Table 2.

Multivariate Cox proportional hazards analyses for overall survival according to clinical parameters and immune cell densities in NSCLC.

HR (95% CI) P
TNM stage (I/II/III/IV) 2.407 (1.513–3.828) 2.09 × 10−4
Age (<60 years versus >60 years) 3.113 (1.368–7.082) 6.78 × 10−3
CD66b/DC-LAMP score
 (LoHi/HiHi/LoLo/HiLo)		 0.474 (0.330–0.680) 4.97 × 10−5

CI, confidence interval.